Simon N M, Sharma S G, Worthington J J, Marzol P C, Pollack M H
Anxiety Disorders Program, Massachusetts General Hospital, Boston 02114, USA.
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct;25(7):1469-74. doi: 10.1016/s0278-5846(01)00189-0.
Social anxiety disorder is a common illness with significant associated disability. Serotonin selective reuptake inhibitors (SSRIs) have become first-line treatment given their improved tolerability; however, there are few reports on the use of citalopram. Nine consecutive patients with a primary diagnosis of DSM-IV generalized social phobia were prospectively treated with citalopram. Citalopram was generally well-tolerated, and seven patients achieved responder status. This series of patients improved significantly on all measures. Results suggest that citalopram may be a safe and effective treatment for social anxiety disorder.
